Cargando…
Clinical features and outcomes of patients with myositis associated-interstitial lung disease
INTRODUCTION: Myositis associated interstitial lung disease (ILD) seems to be an under-recognized entity. METHODS: In this multicenter, retrospective study, we recorded between 9/12/2019 and 30/9/2021 consecutive patients who presented in five different ILD centers from two European countries (Greec...
Autores principales: | Karampitsakos, Theodoros, Tzilas, Vasilios, Papaioannou, Ourania, Chrysikos, Serafeim, Vasarmidi, Eirini, Juge, Pierre-Antoine, Vizirianaki, Styliani, Bibaki, Eleni, Reppa, Argyro, Sidiropoulos, Prodromos, Katsaras, Matthaios, Sotiropoulou, Vasilina, Tsiri, Panagiota, Koulousousa, Electra, Theochari, Eva, Tsirikos, Georgios, Christopoulos, Ioannis, Malakounidou, Elli, Zarkadi, Eirini, Sampsonas, Fotios, Hillas, Georgios, Karageorgas, Theofanis, Daoussis, Dimitrios, Kalogeropoulou, Christina, Dimakou, Katerina, Tzanakis, Nikolaos, Borie, Raphael, Dieudé, Philippe, Antoniou, Katerina, Crestani, Bruno, Bouros, Demosthenes, Tzouvelekis, Argyris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868310/ https://www.ncbi.nlm.nih.gov/pubmed/36698813 http://dx.doi.org/10.3389/fmed.2022.1096203 |
Ejemplares similares
-
Post-COVID-19 interstitial lung disease: Insights from a machine learning radiographic model
por: Karampitsakos, Theodoros, et al.
Publicado: (2023) -
Corrigendum: Post-COVID-19 interstitial lung disease: Insights from a machine learning radiographic model
por: Karampitsakos, Theodoros, et al.
Publicado: (2023) -
Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial
por: Karampitsakos, Theodoros, et al.
Publicado: (2023) -
Tocilizumab improves 28-day survival in hospitalized patients with severe COVID-19: an open label, prospective study
por: Karampitsakos, Theodoros, et al.
Publicado: (2021) -
High-Flow vs. Low-Flow Nasal Cannula in Reducing Hypoxemic Events During Bronchoscopic Procedures: A Systematic Review and Meta-Analysis
por: Sampsonas, Fotios, et al.
Publicado: (2022)